HOME     CONTACT     BACK

 
 
 
THE PHARMA REVIEW AUGUST 06

Pharmacovigilance in Clinical Trials

R.K. Rishi

Abstracts: The importance of Pharmacovigilance in drug safety is well established. The role of Pharmacovigilance has traditionally been focused on detection and evaluation of signals for new adverse drug reactions (ADRs) in the post-approval scenario in order to secure early detection and to introduce measures to manage those risks. However, there is also need to incorporate newer approaches for managing safety information in the clinical trial setting and to implement the methods and tools used in post-approval pharmacovigilance to the early and late stages of pre-market development of medicinal products.

 

The above content is an abstract only. For the full Article please contact:
KONGPOSH Publications Pvt. Ltd.
ICS House, C-19, Commercial Complex, SDA, Opp. IIT Gate, New Delhi, India -110016
Tel.: 26855839, 20057149, Fax: 91-11-26855876
Email: info@kppub.com / fpc@vsnl.com, Website: http://www.kppub.com

 
 
 

 Copyright © 2008. KONGPOSH PUBLICATIONS Pvt. Ltd.